Jia-You Fang Selected Research

Phytotherapy (Herbal Therapy)

7/2019	Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
1/2019	Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: covalent coupling and phospholipid complexation approaches.
10/2018	Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma.
10/2018	Decorating protein nanospheres with lactoferrin enhances oral COX-2 inhibitor/herbal therapy of hepatocellular carcinoma.
10/2018	Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia-You Fang Research Topics

Disease

42	Neoplasms (Cancer) 11/2021 - 01/2005
27	Inflammation (Inflammations) 02/2022 - 10/2009
22	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 02/2008
14	Infections 10/2021 - 11/2013
11	Melanoma (Melanoma, Malignant) 01/2017 - 05/2006
8	Wounds and Injuries (Trauma) 02/2021 - 03/2006
8	Lung Neoplasms (Lung Cancer) 10/2020 - 01/2017
7	Erythema 01/2022 - 05/2008
7	Skin Diseases (Skin Disease) 01/2022 - 01/2014
6	Hyperplasia 04/2022 - 04/2007
6	Skin Neoplasms (Skin Cancer) 01/2021 - 04/2006
5	Hemolysis 03/2012 - 10/2006
4	Dermatitis 01/2022 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2018
4	Carcinogenesis 11/2019 - 11/2009
4	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2006
3	Hypersensitivity (Allergy) 01/2021 - 01/2016
3	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2011
3	Lung Injury 01/2020 - 03/2013
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2018
3	Liver Neoplasms (Liver Cancer) 01/2020 - 10/2018
3	Acute Lung Injury 03/2018 - 09/2015
3	Pain (Aches) 05/2017 - 04/2008
3	Alopecia (Baldness) 08/2015 - 01/2014
2	Body Weight (Weight, Body) 02/2022 - 01/2015
2	Obesity 02/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 12/2020 - 02/2019
2	Necrosis 04/2020 - 04/2010
2	Pneumonia (Pneumonitis) 01/2020 - 01/2018
2	Glioma (Gliomas) 01/2020 - 01/2019
2	Fibrosis (Cirrhosis) 12/2019 - 01/2018
2	Atopic Dermatitis (Atopic Eczema) 01/2019 - 04/2018
2	Abscess 06/2018 - 01/2017
2	Rheumatoid Arthritis 01/2018 - 09/2008

Drug/Important Bio-Agent (IBA)

39	Pharmaceutical PreparationsIBA 01/2021 - 01/2005
18	LipidsIBA 02/2022 - 10/2006
12	Liposomes (Liposome)IBA 10/2021 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2009
7	Imiquimod (Aldara)FDA LinkGeneric 04/2022 - 01/2015
6	Phosphodiesterase 4 InhibitorsIBA 01/2021 - 08/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2018
5	ResveratrolIBA 01/2021 - 04/2007
5	LactoferrinIBA 10/2020 - 01/2018
4	PolymersIBA 01/2021 - 01/2017
4	AlbuminsIBA 12/2020 - 10/2018
4	FlavonoidsIBA 05/2020 - 08/2011
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2020 - 01/2013
4	MicellesIBA 04/2020 - 04/2007
4	LigandsIBA 01/2020 - 06/2018
4	Biological ProductsIBA 05/2019 - 04/2013
4	BerberineIBA 10/2018 - 01/2018
4	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2018 - 03/2013
3	IsoflavonesIBA 04/2022 - 11/2008
3	InterleukinsIBA 01/2022 - 01/2019
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2016
3	CytokinesIBA 02/2021 - 06/2018
3	Oleic Acid (Oleate)IBA 01/2020 - 01/2019
3	LipopolysaccharidesIBA 01/2020 - 09/2016
3	magnololIBA 01/2020 - 01/2017
3	Conditioned Culture MediaIBA 01/2020 - 11/2007
3	Phospholipids (Phosphatides)FDA LinkGeneric 07/2019 - 09/2018
3	ProdrugsIBA 01/2019 - 01/2009
3	PhytochemicalsIBA 10/2018 - 11/2016
3	AntioxidantsIBA 08/2016 - 10/2010
3	SolutionsIBA 01/2015 - 01/2005
3	CamptothecinIBA 08/2013 - 01/2009
3	HydrogelsIBA 07/2012 - 05/2008
3	Cisplatin (Platino)FDA LinkGeneric 10/2009 - 04/2007
2	chrysophanic acidIBA 02/2022 - 01/2022
2	CholesterolIBA 02/2022 - 01/2019
2	rheinIBA 02/2022 - 01/2022
2	Virulence Factors (Pathogenicity Factors)IBA 10/2021 - 12/2015
2	ChemokinesIBA 01/2021 - 06/2018
2	monooleinIBA 10/2020 - 01/2019
2	Caspase 3 (Caspase-3)IBA 10/2020 - 11/2019
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 10/2020 - 04/2020
2	Urethane (Ethyl Carbamate)IBA 10/2020 - 01/2019
2	Thalidomide (Thalomid)FDA Link 08/2020 - 10/2018
2	Etoposide (VP 16)FDA LinkGeneric 04/2020 - 10/2018
2	CalciumIBA 01/2020 - 03/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 10/2009
2	CC ChemokinesIBA 01/2020 - 01/2019
2	RolipramIBA 01/2020 - 09/2015
2	Retinaldehyde (Retinal)IBA 12/2019 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 11/2019 - 01/2016
2	Pemetrexed (MTA)FDA Link 01/2019 - 01/2019
2	CilomilastIBA 01/2019 - 03/2018
2	Diosmin (Daflon)IBA 10/2018 - 10/2018
2	Sirolimus (Rapamycin)FDA Link 09/2018 - 01/2018

Therapy/Procedure

31	Therapeutics 01/2022 - 10/2009
10	Lasers (Laser) 01/2022 - 04/2006
7	Drug Therapy (Chemotherapy) 04/2020 - 02/2008
5	Phytotherapy (Herbal Therapy) 07/2019 - 10/2018
3	Solid-State Lasers 02/2021 - 03/2004
2	Injections 01/2020 - 01/2017
2	Topical Administration 01/2019 - 03/2016
2	Photochemotherapy (Photodynamic Therapy) 11/2018 - 04/2006